The role of capillaroscopy in differentiation of primary and secondary Raynaud's phenomenon in rheumatic diseases: A review of the literature and two case reports

Rheumatology International

Volumn 29, Issue 11, 2009, Pages 1263-1271

  Lambova, Sevdalina Nikolova ^a   Müller Ladner, Ulf ^b,c  

^a MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c KERCKHOFF HEART CENTER   (Germany)

Author keywords

Capillaroscopy; Raynaud's phenomenon; Rheumatic diseases

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CHLOROQUINE; PENTOXIFYLLINE;

ADULT; ANGIOGENESIS; ARTHRITIS; BLEEDING; CAPILLAROSCOPY; CAPILLARY; CASE REPORT; CLINICAL EXAMINATION; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; DERMATOSCOPE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; EARLY DIAGNOSIS; EDEMA; EQUIPMENT; FEMALE; FINGER EDEMA; HUMAN; KNOWLEDGE; LABORATORY TEST; MEDICAL LITERATURE; MEDICAL PRACTICE; MICROCIRCULATION; MICROSCOPE; MIXED CONNECTIVE TISSUE DISEASE; OPHTALMOSCOPE; POLYMYOSITIS; PREDICTION; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCLERODERMA; SJOEGREN SYNDROME; SKIN BLOOD FLOW; SKIN TEMPERATURE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; X RAY ANALYSIS;

ADULT; CONNECTIVE TISSUE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICROCIRCULATION; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; RAYNAUD DISEASE; RHEUMATIC DISEASES; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; SKIN;

EID: 69049085514     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1019-z     Document Type: Review

References (80)

1. S Cortes M Cutolo 2007 Capillaroscopic patterns in rheumatic diseases Acta Rheumatol Port 32 29 36
2. AC Shore 2000 Capillaroscopy and measurement of capillary pressure Br J Clin Pharmacol 50 6 501 513 10.1046/j.1365-2125.2000.00278.x
3. W Grassi R De Anglis 2007 Capillaroscopy: questions and answers Clin Rheumatol 26 2009 2016 10.1007/s10067-007-0681-3
4. Ulf Müller-Ladner (2008) Raynaud's phenomenon and peripheral ischemic syndromes, 1st edn. UNI-MED Verlag AG, Bremen
5. HR Maricq EC LeRoy WA D'Angelo, et al. 1980 Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders Arthritis Rheum 23 2 183 189 10.1002/art.1780230208
6. Bollinger A, Fagrell B (1990) Clinical capillaroscopy - a guide to its use in clinical research and practice. Hogrete&Huber Publishers, Toronto, Ontario, pp 1-158
7. R Bergman L Sharony D Schapira, et al. 2003 The handheld dermatoscope as a nail-foiled capillaroscopic instrument Arch Dermatol 139 1027 1030 10.1001/archderm.139.8.1027
8. M Cutolo W Grassi M Matucci Cerinic 2003 Raynaud's phenomenon ant the role of capillaroscopy Arthritis Rheum 48 11 3023 3030 10.1002/art.11310
9. M Cutolo A Sulli C Pizzorni S Accardo 2000 Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis J Rheumatol 27 155 160
10. M Cutolo C Pizzorni M Tuccio, et al. 2004 Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis Rheumatol 43 719 726 10.1093/rheumatology/keh156
11. M Cutolo C Pizzorni A Sulli 2005 Capillaroscopy Best Pract Res Clin Rheumatol 19 3 437 452 10.1016/j.berh.2005.01.001
12. M Cutolo A Sulli ME Secchi, et al. 2007 The contribution of capillaroscopy to the differential diagnosis of connective autoimmune diseases Best Pract Res Clin Rheumatol 21 6 1093 1108 10.1016/j.berh.2007.10.001
13. M Bredemeier RM Xavier KG Capobianco, et al. 2004 Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis J Rheumatol 31 286 294
14. P Dolezalova SP Young PA Bacon TR Southwood 2003 Nailfold capillary microscopy in healthy children and in childhood rheumatic diseases: a prospective single blind observational study Ann Rheum Dis 62 5 444 449 10.1136/ard.62.5.444
15. Y Kabasakal DM Elvins EF Ring NJ McHugh 1996 Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls Ann Rheum Dis 55 507 512 10.1136/ard.55.8.507
16. P Lee FY Leung C Alderdice SK Armstrong 1983 Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment J Rheumatol 10 6 930 938
17. F Lefford JCW Edwards 1986 Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis Ann Rheum Dis 45 741 749 10.1136/ard.45.9.741
18. HR Maricq FE Harper MM Khan, et al. 1983 Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease Clin Exp Rheumatol 1 3 195 205
19. HR Maricq 1986 Comparison of quantitative and semiquantitative estimates of nailfold capillary abnormalities in scleroderma spectrum disorders Microvasc Res 32 2 271 276 10.1016/0026-2862(86)90062-2
20. W Redisch 1970 Capillaroscopic observations in rheumatic diseases Ann Rheum Dis 29 244 253 10.1136/ard.29.3.244
21. HJ Anders T Sigl M Schattenkirchner 2001 Differentiation between primary and secondary Raynaud's phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope Ann Rheum Dis 60 407 409 10.1136/ard.60.4.407
22. E Beltran A Toll A Pros, et al. 2007 Assessment of nailfold capillaroscopy by ×30 digital epiluminescence (dermoscopy) in patients with Raynaud's phenomenon Clin Lab Invest 156 892 898
23. ME Anderson PD Allen T Moore, et al. 2005 Computerized nailfold videocapillaroscopy-a new tool for assessment of Raynaud's phenomenon J Rheumatol 32 841 848
24. AL Herrick 2008 Diagnosis and management of scleroderma peripheral vascular disease Rheum Dis Clin North Am 34 89 114 10.1016/j.rdc.2007.11.006
25. M Ho JJF Belch 1998 Raynaud's phenomenon: State of the Art 1998 Scand J Rheumatol 27 319 322 10.1080/03009749850154311
26. M Cutolo A Sulli ME Secchi, et al. 2006 Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatol 45 43 46 10.1093/rheumatology/kel310
27. AL Herrick S Clark 1998 Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis Ann Rheum Dis 57 70 78
28. JA Block W Sequeira 2001 Raynaud's phenomenon Sem Lancet 357 2042 2048 10.1016/S0140-6736(00)05118-7
29. Seibold JR, Steen VD (1994) Systemic sclerosis. In: Klippel JH, Dieppe PA (eds) Rheumatology. London, Mosby, pp 6.8-6.11
30. Steven AO (2001) Raynaud's phenomenon. In: Sterling JB (ed) Secrets of rheumatology. Binom, Moscow, pp 614-619
31. E Susol AJ MacGregor JH Barrett, et al. 2000 A two- stage, genome-wide screen for susceptibility loci in primary Raynaud's phenomenon Arthritis Rheum 43 7 1641 1646 10.1002/1529-0131(200007)43:7<1641::AID-ANR30>3.0.CO;2-Y
32. EC Le Roy TA Medsger Jr 1992 Raynaud's phenomenon-a proposal for classification Clin Exp Rheumatol 10 485 488
33. M Bukhari S Hollis T Moore, et al. 2000 Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by videocapillaroscopy Rheumatol 39 5 506 512 10.1093/rheumatology/39. 5.506
34. Z Nagy L Czirjac 2004 Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud' disease J Eur Acad Dermatol Venereol 18 62 68 10.1111/j.1468-3083.2004.00853.x
35. D Blockmans G Beyens R Verhaeghe 1996 Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases Clin Rheumatol 15 2 148 153 10.1007/BF02230332
36. S Pavlov-Dolijanovic N Damjanov P Ostojić, et al. 2006 The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary Raynaud's phenomenon: a follow-up study of 250 patients Pediatr Dermatol 23 5 437 442 10.1111/j.1525-1470.2006.00278.x
37. S Ziegler M Brunner E Eigenbauer E Minar 2003 Long-term outcome of primary Raynaud's phenomenon and its conversion to connective tissue disease: a 12-year prospective patient analysis Scand J Rheumatol 32 343 347 10.1080/03009740410005007
38. Kirou KA, Crow MK (2000) Raynaud's phenomenon. In: Paget SA et al (eds) Manual of rheumatology and outpatient orthopedic disorders: diagnosis and therapy, 4th edn. Lippincot Williams & Willkins, Philadelphia, pp 82-87
39. SM Ling FM Wigley 1999 Raynaud's phenomenon in older adults. Diagnostic considerations and management Drugs Aging 15 3 183 195 10.2165/00002512- 199915030-00002
40. NS Sherber FM Wigley R Scher 2007 Autoimmune disorders: nail signs and therapeutic approaches Dermatol Ther 20 1 17 30 10.1111/j.1529-8019.2007.00108.x
41. Silver RM (2005) Systemic sclerosis and scleroderma variants:clinical aspects. In: Koopman WJ et al (eds) Arthritis and allied conditions, 15th edn. Lippincot Williams &Wilkins, Philadelphia, pp 1633-1680
42. MJ Mulligan-Kehoe M Simons 2008 Vascular disease in scleroderma: angiogenesis and vascular repair Rheum Dis Clin North Am 34 73 79 10.1016/j.rdc.2007.12.006
43. P Caramaschi S Canestrini N Martinelli, et al. 2007 Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity Rheumatol 46 10 1566 1569 10.1093/rheumatology/kem190
44. PM Houtman CG Kallenberg AA Wouda TH The 1985 Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunologically mediated local and systemic vascular disease? Ann Rheum Dis 44 603 609 10.1136/ard.44.9.603
45. P Ostojic N Damjanov 2006 Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis Clin Rheumatol 25 453 457 10.1007/s10067-005-0041-0
46. M Lovy D MacCarter JC Steigerwald 1985 Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis Arthritis Rheum 28 5 496 501 10.1002/art.1780280505
47. A Masi GP Rodnan TA Medsger, et al. 1980 Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Arthritis Rheum 23 581 590 10.1002/art.1780230510
48. LS Lonzetti F Joyal JP Raynauld, et al. 2001 Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma Arthritis Rheum 44 3 735 736 10.1002/1529-0131(200103)44:3<735::AID-ANR125>3.0.CO;2-F
49. JG Walker 2007 The development of systemic sclerosis classification criteria Clin Rheumatol 26 1401 1409 10.1007/s10067-007-0537-x
50. M Hudson S Taillefer R Steele, et al. 2007 Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis Clin Exp Rheumatol 25 5 754 757
51. EC Le Roy TA Medsger Jr 2001 Criteria for the classification of early systemic sclerosis J Rheumatol 28 573 576
52. Maricq HR, Valter I (2004) A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 22(3)(Suppl 33):S5-S13
53. O Nadashkevich P Davis MJ Fritzler 2004 A proposal of criteria for the classification of systemic sclerosis Med Sci Monit 10 11 CR615 CR621
54. F Granier P Priollet E Housset 1986 Nailfold capillary microscopy in mixed connectivetissue disease. Comparison with systemic sclerosis and systemic lupus erythematosus Arthritis Rheum 29 2 189 195 10.1002/art.1780290206
55. RNV Furtado ML Pucinelli VV Cristo, et al. 2002 Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients Lupus 11 1 35 41 10.1191/0961203302lu144oa
56. H Groen EJ ter Borg DS Postma, et al. 1992 Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns Am J Med 93 6 619 627 10.1016/0002-9343(92)90194-G
57. F Ingegnoli S Zeni L Meani, et al. 2005 Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus J Clin Rheumatol 11 6 295 298 10.1097/01.rhu.0000191193.93720.95
58. O Bongard H Bounameaux PA Miescher P De Moerloose 1995 Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus Lupus 4 2 142 144 10.1177/096120339500400211
59. V Riccieri A Spadaro F Ceccarelli, et al. 2005 Nailfold capillaroscopy changes in systemic lupus erythematosus: correlation with disease activity and autoantibody profile Lupus 14 521 525 10.1191/0961203305lu2151oa
60. RA Asherson SS Pierangeli R Cervera 2007 Is there a microangiopathic antiphospholipid syndrome? Ann Rheum Dis 66 429 432 10.1136/ard.2006.067033
61. M Pallis N Hopkinson R Powell 1991 Nailfold capillary density as a possible indicator of pulmonary capillary loss in systemic lupus erythematosus but not in mixed connective tissue disease J Rheumatol 18 10 1532 1536
62. ML Ganczarczyk Armstrong SK Lee 1988 Nailfold capillary microscopy in polymyositis and dermatomyositis Arthritis Rheum 31 1 116 119 10.1002/art.1780310116
63. AK Nascif MT Terreri CA Len, et al. 2006 Inflammatory myopathies in childhood: correlation between nailfold capillaroscopy findings and clinical and laboratory data J Pediatr 82 40 45 10.2223/JPED.1435
64. JS Smolen G Steiner 1998 Mixed connective tissue disease: to be or not to be? Arthritis Rheum 41 5 768 777 10.1002/1529-0131(199805)41:5<768::AID- ART3>3.0.CO;2-Z
65. A de Holanda Mafaldo Diógenes E Bonfá R Fuller MT Correia Caleiro 2007 Capillaroscopy is a dynamic process in mixed connective tissue disease Lupus 16 4 254 258 10.1177/0961203307076517
66. M Garcia-Carrasco A Sisó M Ramos-Casals, et al. 2002 Raynaud's phenomenon in primary Sjogren's syndrome. Prevalence and clinical characteristics in a series of 320 patients J Rheumatol 29 726 730
67. M Tektonidou E Kaskani FN Skopouli HM Moutsopoulos 1999 Microvascular abnormalities in SjÖgren's syndrome: nailfold capillaroscopy Rheumatol 38 826 830 10.1093/rheumatology/38.9.826
68. KG Capobianco RM Xavier M Bredemeier, et al. 2005 Nailfold capillaroscopic findings in primary Sjögren's syndrome: clinical and serological correlations Clin Exp Rheumatol 23 6 789 794
69. T Aguiar E Furtado D Dorigo, et al. 2006 Nailfold videocapillaroscopy in primary SjÖgren's syndrome Angiology 57 5 593 599 10.1177/0003319706293127
70. GJ Carrol K Withers CE Bayliss 1981 The prevalence of Raynaud's syndrome in rheumatoid arthritis Ann Rheum Dis 40 567 570 10.1136/ard.40.6.567
71. W Grassi P Blasetti P Core C Cervini 1994 Raynaud's phenomenon in rheumatoid arthritis Br J Rheumatol 33 139 141 10.1093/rheumatology/33.2.139
72. A Saraux J Allain C Guedes, et al. 1996 Raynaud's phenomenon in rheumatoid arthritis Br J Rheumatol 35 8 752 754 10.1093/rheumatology/35.8.752
73. W Grassi M Felder U Thüring-Vollenweider A Bollinger 1989 Microvascular dynamics at the nailfold in rheumatoid arthritis Clin Exp Rheumatol 7 1 47 53
74. M Bhushan T Moore AL Herrick CE Griffiths 2000 Nailfold video capillaroscopy in psoriasis Br J Dermatol 142 1171 1176 10.1046/j.1365-2133. 2000.03544.x
75. L Salli F Raimondi A Pappalardo 1999 Periungual capillaroscopy in psoriatic arthritis Clin Term 150 6 409 412 Abstract
76. JL Vaz MA Dancour DA Bottino E Bouskela 2004 Nailfold videocapillaroscopy in primary antiphospholipid syndrome Rheumatol 43 1025 1027 10.1093/rheumatology/keh233
77. G Filaci M Cutolo M Basso, et al. 2001 Long-term treatment of patients affected by systemic sclerosis with cyclosporin A Rheumatology 40 12 1431 1432 10.1093/rheumatology/40.12.1431 letter
78. M Hahn T Klyscz M Jünger G Rassner 1995 Local cold exposure test as therapy control in patients with Raynaud's phenomenon: comparison between laser Doppler fluxmetry and simultaneous red blood cell velocity measurements in nailfold capillaries Br J Dermatol 133 5 704 709
79. A Schlez HM Häfner M Kittel, et al. 2003 Systemic scleroderma patients have improved skin perfusion after the transdermal application of PGE1 ethyl ester Vasa 32 2 83 86 10.1024/0301-1526.32.2.83
80. B Combe R Landewe C Lukas, et al. 2007 EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) Ann Rheum Dis 66 34 45 10.1136/ard.2005.044354